Skip to main content
Premium Trial:

Request an Annual Quote

Sydney Brenner Co-founds Company to Develop New Sequencing Platform

NEW YORK, April 20 (GenomeWeb News) - Sydney Brenner has devised a new way to obtain sequence information from thousands of genomes simultaneously, and has co-founded a new company to help develop the platform, according to the Wellcome Trust.


The Wellcome Trust has given the company, called Population Genetics Technologies, a £1.1 million ($2.1 million) Programme Related Investment grant to help it start developing the technology. The money will appear as soon as the company receives "additional" venture capital funding, the Wellcome Trust added.


It was not immediately clear how much private-equity financing the company has so far received, or from whom.


The intellectual property and related patent applications underlying the technology were licensed from Compass Genetics, a partnership formed several years ago by Brenner; Sam Eletr, a current director at Third Wave Technologies and former director at Solexa and Lynx Therapeutics; and Philip Goelet, director of Red Abbey Venture Partners, a UK-based private-equity firm. Additional information about the platform was not disclosed.


Population Genetics Technologies will be located in Cambridge, UK. Eletr will be acting-CEO until the role is permanently filled. Brenner and Eletr will sit on the board, which will be chaired by Mark Treherne, chairman of Neurosolutions, a UK-based biotech company.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.